The Tacticon ™ is a small, hand held, passive medical device that the FDA has recently allowed to be marketed to screen patients for evidence of subclinical peripheral neuropathy of the fingers and toes. The Tacticon ™ permits quantitative sensory testing (QST) as recommended by the American Diabetes Association Consensus Panels on Diabetic Peripheral Neuropathy.
Get More Information About This Product